Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Humacyte, Inc.

NASDAQ: HUMA · Life Sciences · 3 alerts · CIK 1818382

Share price
$0.5403Close, Nov 16
Market cap
$150M
Shares outstanding
277.8MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Humacyte, Inc. filings on SEC EDGAR ↗

4:06 PM ET 8-K
Leadership Change

Humacyte Leadership Change

Humacyte, Inc. appointed life science industry veterans Scott Coward and Paul Kuznik to its Board of Directors, effective September 22, 2026. Coward, a former executive at Exact Sciences, and Kuznik, a former CEO of Bolton Medical, bring extensive experience in commercialization and global operations as the company prepares for the planned launch of its ATEV product in dialysis access.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.